Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma

Xin Wu,Tao Mi,Liming Jin,Chunnian Ren,Jinkui Wang,Zhaoxia Zhang,Jiayan Liu,Zhaoyin Wang,Peng Guo,Dawei He

DOI: https://doi.org/10.1007/s00262-024-03702-9

IF: 6.63

2024-05-08

Cancer Immunology Immunotherapy

Abstract:Neuroblastoma (NB) is the most common and deadliest extracranial solid tumor in children. Targeting tumor-associated macrophages (TAMs) is a strategy for attenuating tumor-promoting states. The crosstalk between cancer cells and TAMs plays a pivotal role in mediating tumor progression in NB. The overexpression of Hexokinase-3 (HK3), a pivotal enzyme in glucose metabolism, has been associated with poor prognosis in NB patients. Furthermore, it correlates with the infiltration of M2-like macrophages within NB tumors, indicating its significant involvement in tumor progression. Therefore, HK3 not only directly regulates the malignant biological behaviors of tumor cells, such as proliferation, migration, and invasion, but also recruits and polarizes M2-like macrophages through the PI3K/AKT-CXCL14 axis in neuroblastoma. The secretion of lactate and histone lactylation alterations within tumor cells accompanies this interaction. Additionally, elevated expression of HK3 in M2-TAMs was found at the same time. Modulating HK3 within M2-TAMs alters the biological behavior of tumor cells, as demonstrated by our in vitro studies. This study highlights the pivotal role of HK3 in the progression of NB malignancy and its intricate regulatory network with M2-TAMs. It establishes HK3 as a promising dual-functional biomarker and therapeutic target in combating neuroblastoma.

oncology,immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the dual role of hexokinase - 3 (HK3) in the interaction network between tumor cells and tumor - associated macrophages (TAMs) in neuroblastoma (NB) and its impact on tumor progression. Specifically, the research aims to:

1. **Clarify the clinical significance of HK3 in neuroblastoma**: By analyzing the relationship between the expression level of HK3 and the prognosis of patients, determine its potential as a biomarker.
2. **Reveal the function of HK3 in tumor cells**: Explore how HK3 directly regulates the malignant biological behaviors of tumor cells, such as proliferation, migration and invasion.
3. **Analyze the role of HK3 in TAMs**: Study whether and how HK3 recruits and polarizes M2 - like macrophages through the PI3K/AKT - CXCL14 axis.
4. **Explore the role of metabolic reprogramming**: Analyze the impact of lactic acid secretion and histone lactylation changes caused by HK3 overexpression on the tumor microenvironment (TME).
5. **Evaluate the potential of HK3 as a therapeutic target**: Verify the therapeutic value of HK3 in neuroblastoma through in vitro and in vivo experiments.

### Research background

Neuroblastoma is the most common and most lethal extracranial solid tumor in children, which is highly invasive and difficult to be completely surgically removed. Treatment strategies targeting TAMs may help slow down the tumor - promoting state. HK3 is an enzyme that plays a key role in the early stage of glucose metabolism. Its overexpression is associated with the poor prognosis of neuroblastoma patients and is related to the infiltration of M2 - like macrophages. Therefore, HK3 not only directly affects the behavior of tumor cells, but also affects the function of TAMs through metabolic pathways, thus playing an important role in the progression of neuroblastoma.

### Main findings

1. **HK3 overexpression is associated with poor prognosis**: Through survival analysis of the TARGET database and clinical samples, it was found that patients with high HK3 expression had a poorer prognosis.
2. **HK3 regulates tumor cell behavior**: HK3 overexpression promotes the proliferation, migration and invasion of tumor cells.
3. **HK3 affects TAMs through the PI3K/AKT - CXCL14 axis**: HK3 recruits and polarizes M2 - like macrophages through this signaling pathway.
4. **Metabolic changes affect TME**: HK3 overexpression leads to increased lactic acid secretion and histone lactylation changes, which in turn affect the TME.
5. **HK3 as a potential therapeutic target**: By knocking down HK3 expression, the malignant behavior of tumor cells can be significantly inhibited and the function of TAMs can be changed.

In conclusion, this study reveals the dual role of HK3 in neuroblastoma and its complex regulatory network, providing an important basis for the development of new diagnostic and treatment strategies.